Pyrrolidine

Pyrrolidine

SCHEMBL95765

[2H]C1([2H])CNCC1([2H])[2H]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyrrolidine SCHEMBL133852 0.95
Azetidine SCHEMBL29444497 0.95
Piperidine SCHEMBL13916947 0.82
Pyrrolidine SCHEMBL13915078 0.79
Azetidine SCHEMBL29378779 0.74
Piperidine SCHEMBL13916948 0.73
Aziridine SCHEMBL3089497 0.71
Aziridine SCHEMBL16878816 0.71
Aziridine SCHEMBL2267 0.71
Aziridine SCHEMBL29376529 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130296279-A1 SUBSTITUTED TETRACYCLINES CONCERT PHARMACEUTICALS INC. 2013-11-07 US disclosed
US-20120058085-A1 Deuterium Modified Benzimidazoles CONCERT PHARMACEUTICALS, INC. 2012-03-08 US disclosed
US-20120058085-A1 Deuterium Modified Benzimidazoles CONCERT PHARMACEUTICALS, INC. 2012-03-08 US disclosed
WO-2010132810-A1 DEUTERIUM MODIFIED BENZIMIDAZOLES CONCERT PHARMACEUTICALS, INC. (US) 2010-11-18 WO disclosed
US-20090062374-A1 DEUTERIUM-ENRICHED LASOFOXIFENE PROTIA, LLC (US) 2009-03-05 US disclosed